×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient.
16266977
2005
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Successful Treatment of Advanced Metastatic Prostate Cancer following Chemotherapy Based on Molecular Profiling.
22666205
2012
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Cellular changes in prostate cancer cells induced by intermittent androgen suppression.
17141945
2007
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Endocrine approaches in the therapy of prostate carcinoma.
15790600
2005
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Endocrine approaches in the therapy of prostate carcinoma.
15790600
2005
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Successful Treatment of Advanced Metastatic Prostate Cancer following Chemotherapy Based on Molecular Profiling.
22666205
2012
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Androgen deprivation therapy for prostate cancer: current status and future prospects.
15389811
2004
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition.
25970160
2015
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Changing paradigms in management of metastatic Castration Resistant Prostate Cancer (mCRPC).
25062956
2014
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.
22610119
2012
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Integrative molecular profiling of routine clinical prostate cancer specimens.
25735316
2015
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies.
25908785
2015
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient.
16266977
2005
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Changing paradigms in management of metastatic Castration Resistant Prostate Cancer (mCRPC).
25062956
2014
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Androgen receptor alterations in prostate cancer relapsed during a combined androgen blockade by orchiectomy and bicalutamide.
11742035
2001
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells.
17003774
2007
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells.
17003774
2007
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor.
19011039
2009
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Androgen deprivation therapy for prostate cancer: current status and future prospects.
15389811
2004
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Androgen receptors in prostate cancer.
12237244
2002
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition.
25970160
2015
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.
22610119
2012
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Integrative molecular profiling of routine clinical prostate cancer specimens.
25735316
2015
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cells.
16877366
2006
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Synthesis and biological evaluation of a nonsteroidal bromine-76-labeled androgen receptor ligand 3-[76Br]bromo-hydroxyflutamide.
16934689
2006